ThermoGenesis Holdings Overview
- Year Founded
-
1986

- Status
-
Public
- Employees
-
25

- Stock Symbol
-
THMO

- Investments
-
3
ThermoGenesis Holdings General Information
Description
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Contact Information
Website
www.thermogenesis.comCorporate Office
- 2711 Citrus Road
- Rancho Cordova, CA 95742
- United States
Corporate Office
- 2711 Citrus Road
- Rancho Cordova, CA 95742
- United States
ThermoGenesis Holdings Stock Performance
As of 06-Feb-2025, ThermoGenesis Holdings’s current market cap is $4.75K with 15.8M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$4.75K | 15.8M | 16.2K | -$5.14 |
ThermoGenesis Holdings Financials Summary
As of 31-Mar-2024, ThermoGenesis Holdings has a trailing 12-month revenue of $9.6M.
In Thousands, USD |
TTM 31-Mar-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 5,233 | 4,879 | 8,495 | 13,803 |
Revenue | 9,610 | 9,445 | 10,483 | 9,294 |
EBITDA | (6,943) | (7,740) | (5,270) | (5,144) |
Net Income | (14,745) | (17,975) | (11,270) | (11,379) |
Total Assets | 10,087 | 11,232 | 19,386 | 20,652 |
Total Debt | 6,926 | 10,556 | 10,365 | 10,456 |
ThermoGenesis Holdings Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
ThermoGenesis Holdings Comparisons
Industry
Financing
Details
ThermoGenesis Holdings Competitors (30)
One of ThermoGenesis Holdings’s 30 competitors is Celyad Oncology, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Celyad Oncology | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
Mirus Bio | Formerly PE-Backed | Madison, WI | ||||
ToolGen | Corporation | Seoul, South Korea | ||||
Precigen | Formerly VC-backed | Germantown, MD | ||||
Orgenesis | Corporation | Germantown, MD |
ThermoGenesis Holdings Patents
ThermoGenesis Holdings Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10823746-B1 | Lateral flow immunoassay test reader and method of use | Active | 22-May-2020 | ||
US-20210364536-A1 | Lateral flow immunoassay test reader and method of use | Inactive | 22-May-2020 | ||
EP-3913368-A1 | Lateral flow immunoassay test reader and method of use | Inactive | 22-May-2020 | ||
EP-3844478-A4 | Methods for isolating target cells from blood | Pending | 31-Aug-2018 | ||
EP-3844478-A1 | Methods for isolating target cells from blood | Pending | 31-Aug-2018 | G01N33/56972 |
ThermoGenesis Holdings Signals
ThermoGenesis Holdings Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
ThermoGenesis Holdings Investments & Acquisitions (3)
ThermoGenesis Holdings’s most recent deal was a Joint Venture with ImmuneCyte Life Sciences. The deal was made on 26-Nov-2019.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
ImmuneCyte Life Sciences | 26-Nov-2019 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
SynGen | 07-Jul-2017 | Merger/Acquisition | Other Devices and Supplies | ||
ThermoGenesis (Acquired 2014) | 19-Feb-2014 | Merger/Acquisition | Therapeutic Devices |
ThermoGenesis Holdings FAQs
-
When was ThermoGenesis Holdings founded?
ThermoGenesis Holdings was founded in 1986.
-
Where is ThermoGenesis Holdings headquartered?
ThermoGenesis Holdings is headquartered in Rancho Cordova, CA.
-
What is the size of ThermoGenesis Holdings?
ThermoGenesis Holdings has 25 total employees.
-
What industry is ThermoGenesis Holdings in?
ThermoGenesis Holdings’s primary industry is Biotechnology.
-
Is ThermoGenesis Holdings a private or public company?
ThermoGenesis Holdings is a Public company.
-
What is ThermoGenesis Holdings’s stock symbol?
The ticker symbol for ThermoGenesis Holdings is THMO.
-
What is the current market cap of ThermoGenesis Holdings?
The current market capitalization of ThermoGenesis Holdings is $4.75K.
-
What is ThermoGenesis Holdings’s current revenue?
The trailing twelve month revenue for ThermoGenesis Holdings is $9.6M.
-
Who are ThermoGenesis Holdings’s competitors?
Celyad Oncology, Mirus Bio, ToolGen, Precigen, and Orgenesis are some of the 30 competitors of ThermoGenesis Holdings.
-
What is ThermoGenesis Holdings’s annual earnings per share (EPS)?
ThermoGenesis Holdings’s EPS for 12 months was -$5.14.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »